NextCell Pharma AB
65G
Company Profile
Business description
NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.
Contact
Karolinska Institutet Science Park
Halsovagen 7
Huddinge14157
SWET: +46 87355595
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
24
Stocks News & Analysis
stocks
Undervalued REIT receives offer from PE firm
Our analysts’ view on the value of the unsolicited offer.
stocks
Apple: With launch of foldable iPhone duo things look twice as nice
We’ve raised our fair value estimate of Apple stock.
stocks
What did Morningstar subscribers buy and sell during August?
Earnings season fuels trading activity.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,920.20 | 13.80 | 0.15% |
| CAC 40 | 8,159.87 | 43.11 | 0.53% |
| DAX 40 | 25,524.42 | 163.27 | 0.64% |
| Dow JONES (US) | 52,064.10 | 316.56 | -0.60% |
| FTSE 100 | 10,658.65 | 49.73 | 0.47% |
| HKSE | 24,805.63 | 148.84 | -0.60% |
| NASDAQ | 26,081.72 | 171.62 | -0.65% |
| Nikkei 225 | 64,011.34 | 1,259.61 | -1.93% |
| NZX 50 Index | 13,580.33 | 130.68 | -0.95% |
| S&P 500 | 7,591.70 | 44.66 | -0.58% |
| S&P/ASX 200 | 8,741.20 | 23.30 | 0.27% |
| SSE Composite Index | 3,888.11 | 46.29 | -1.18% |